Clinical trial
Systematically Mediastinal Lymph Node Dissection or Not in Stage T1 Ground-glass Dominated Invasive Lung Adenocarcinoma: a Multi-center, Prospective Clinical Trial
NCT04527419 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systematically Mediastinal Lymph Node Dissection or Not in Stage T1 Ground-glass Dominated Invasive Lung Adenocarcinoma: a Multi-center, Prospective Clinical Trial
- Lead sponsor
- Fudan University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 9, 2022
- Completion date
- February 9, 2027
- Enrollment
- 545 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.